By Asher Mullard writing for nature
Photo by Louis Reed on Unsplash
A US$2-million, 8-year attempt to replicate influential preclinical cancer research papers has released its final — and disquieting — results. Fewer than half of the experiments assessed stood up to scrutiny, reports the Reproducibility Project: Cancer Biology (RPCB) team in eLife1,2. The project — one of the most robust reproducibility studies performed so far — documented how hurdles including vague research protocols and uncooperative authors delayed the initiative by five years and halved its scope.
Read the full article on nature